IRIS
LAMBERTINI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 22.871
NA - Nord America 4.348
AS - Asia 3.848
Continente sconosciuto - Info sul continente non disponibili 1.102
SA - Sud America 383
AF - Africa 71
OC - Oceania 8
Totale 32.631
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 21.914
US - Stati Uniti d'America 4.056
SG - Singapore 1.403
CN - Cina 978
VN - Vietnam 533
BD - Bangladesh 509
FI - Finlandia 305
FR - Francia 295
BR - Brasile 222
HK - Hong Kong 142
DE - Germania 133
CA - Canada 120
MX - Messico 56
AR - Argentina 51
GB - Regno Unito 45
JP - Giappone 45
IN - India 36
ID - Indonesia 34
NL - Olanda 30
EC - Ecuador 29
CO - Colombia 27
ES - Italia 24
CR - Costa Rica 22
JM - Giamaica 22
IQ - Iraq 19
RU - Federazione Russa 19
CH - Svizzera 18
MY - Malesia 16
PH - Filippine 16
ZA - Sudafrica 16
AT - Austria 14
PY - Paraguay 14
VE - Venezuela 14
IE - Irlanda 13
UA - Ucraina 13
CL - Cile 12
PK - Pakistan 12
UZ - Uzbekistan 12
GT - Guatemala 11
HN - Honduras 11
SA - Arabia Saudita 10
TR - Turchia 10
TT - Trinidad e Tobago 10
KE - Kenya 9
JO - Giordania 8
KR - Corea 8
MA - Marocco 8
SV - El Salvador 8
AU - Australia 7
DZ - Algeria 7
SC - Seychelles 7
TH - Thailandia 7
TW - Taiwan 7
BE - Belgio 6
KW - Kuwait 6
NI - Nicaragua 6
SE - Svezia 6
BG - Bulgaria 5
NP - Nepal 5
PR - Porto Rico 5
TN - Tunisia 5
AL - Albania 4
AZ - Azerbaigian 4
BO - Bolivia 4
BS - Bahamas 4
DO - Repubblica Dominicana 4
KZ - Kazakistan 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AM - Armenia 3
BB - Barbados 3
CZ - Repubblica Ceca 3
EG - Egitto 3
IL - Israele 3
IR - Iran 3
LB - Libano 3
PE - Perù 3
PL - Polonia 3
RO - Romania 3
SI - Slovenia 3
BY - Bielorussia 2
CG - Congo 2
CI - Costa d'Avorio 2
CU - Cuba 2
GA - Gabon 2
GR - Grecia 2
LC - Santa Lucia 2
LY - Libia 2
MK - Macedonia 2
MR - Mauritania 2
PT - Portogallo 2
RS - Serbia 2
SY - Repubblica araba siriana 2
BF - Burkina Faso 1
BH - Bahrain 1
BM - Bermuda 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
CD - Congo 1
CY - Cipro 1
GD - Grenada 1
Totale 31.508
Salva come PNG Salva come JPEG
Città #
Genova 9.523
Genoa 8.289
Vado Ligure 1.817
Rapallo 1.564
San Jose 817
Ashburn 655
Singapore 620
Helsinki 284
Council Bluffs 280
Lauterbourg 261
Beijing 168
New York 164
Ho Chi Minh City 155
Hong Kong 132
Santa Clara 131
Hanoi 124
Frankfurt am Main 76
Bordighera 74
Los Angeles 71
Milan 57
Boardman 50
Buffalo 46
Phoenix 46
Rome 45
St Louis 44
Chicago 40
Dallas 38
Naples 35
Tokyo 34
Toronto 31
Mexico City 30
Haiphong 27
Tianjin 27
Atlanta 25
Da Nang 25
São Paulo 25
Schiffdorf 23
Orem 22
Philadelphia 22
Houston 20
Lappeenranta 20
Miami 20
San José 19
Brooklyn 18
Columbus 18
Amsterdam 16
Seattle 16
Bologna 15
Newark 15
Orlando 15
Zurich 15
Guangzhou 14
Kingston 14
Brasília 13
Dublin 13
Palermo 13
Bari 12
Montreal 12
Taranto 12
Tashkent 12
Florence 11
Quito 11
Washington 11
Boston 10
City of London 10
Curitiba 10
Guatemala City 10
Asunción 9
Jacksonville 9
Johannesburg 9
Louisville 9
Shanghai 9
The Bronx 9
Vienna 9
Agawam 8
Brescia 8
Hải Dương 8
Kuala Lumpur 8
London 8
Nuremberg 8
Padua 8
Richmond 8
San Salvador 8
Shenzhen 8
Amman 7
Baghdad 7
Detroit 7
Fort Lauderdale 7
Guayaquil 7
Madrid 7
Nairobi 7
Nashville 7
Phủ Lý 7
Pittsburgh 7
Princeton 7
Queens 7
San Antonio 7
Surrey 7
Thái Bình 7
Turin 7
Totale 26.547
Salva come PNG Salva come JPEG
Nome #
Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and meta-analysis 244
The five "Ws" for bone pain due to the administration of granulocyte-colony stimulating factors (G-CSFs) 233
Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast malignancies: a systematic review and meta-analysis 228
Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study 211
Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studies 210
Cancer and fertility preservation: international recommendations from an expert meeting 209
Italian survey on managing immune checkpoint inhibitors in oncology during COVID-19 outbreak 209
State of the art on oocyte cryopreservation in female cancer patients: A critical review of the literature 205
Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study 201
Reproductive behaviors and risk of developing breast cancer according to tumor subtype: A systematic review and meta-analysis of epidemiological studies 198
Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO) 197
Management of young women with early breast cancer 194
Progesterone receptor status and clinical outcome in breast cancer patients with estrogen receptor-positive locoregional recurrence 190
The PREgnancy and FERtility (PREFER) study: An Italian multicenter prospective cohort study on fertility preservation and pregnancy issues in young breast cancer patients 190
Gonadotropin-releasing hormone agonists during chemotherapy for preservation of ovarian function and fertility in premenopausal patients with early breast cancer: A systematic review and meta-analysis of individual patient–level data 186
Temporary Ovarian Suppression With Gonadotropin-Releasing Hormone Agonist During Chemotherapy for Fertility Preservation: Toward the End of the Debate? 186
Anthracyclines strike back: Rediscovering non‐pegylated liposomal doxorubicin in current therapeutic scenarios of breast cancer 185
Adverse events and impact on quality of life of antibody-drug conjugates in the treatment of metastatic breast cancer: A systematic review and meta-analysis 184
Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study 182
Hormonal therapy followed by chemotherapy or the reverse sequence as first-line treatment of hormone-responsive, human epidermal growth factor receptor-2 negative metastatic breast cancer patients: Results of an observational study 182
Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis 179
Diagnosis of lung cancer following emergency admission: Examining care pathways, clinical outcomes, and advanced NSCLC treatment in an Italian cancer Center 176
New insights on the role of luteinizing hormone releasing hormone agonists in premenopausal early breast cancer patients 171
News on the medical treatment of young women with early-stage HER2-negative breast cancer 171
Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis 171
Patterns of care and clinical outcomes of first-line trastuzumab-based therapy in HER2-positive metastatic breast cancer patients relapsing after (Neo)adjuvant trastuzumab: An Italian multicenter retrospective cohort study 171
Biology, staging, and treatment of breast cancer during pregnancy: reassessing the evidences 169
Pegfilgrastim administration after 24 or 72 or 96 h to allow dose-dense anthracycline- and taxane-based chemotherapy in breast cancer patients: a single-center experience within the GIM2 randomized phase III trial 168
T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational Study 168
Adherence to guidelines in requesting oncotype DX in a publicly funded health care system 167
Treatment with aromatase inhibitors and markers of cardiovascular disease 166
New emerging targets in cancer immunotherapy beyond CTLA-4, PD-1 and PD-L1: Introducing an "ESMO Open-Cancer Horizons" Series 166
The BCY3/BCC 2017 survey on physicians' knowledge, attitudes and practice towards fertility and pregnancy-related issues in young breast cancer patients 165
Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: Systematic review and meta-analysis of randomized trials 164
Beyond fertility preservation: role of the oncofertility unit in the reproductive and gynecological follow-up of young cancer patients 164
Pharmacotherapy to protect ovarian function and fertility during cancer treatment 162
Anti-Mullerian hormone: determination of ovarian reserve in early breast cancer patients 162
Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients 162
Adjuvant trastuzumab: a 10-year overview of its benefit 161
Burning Questions in the Oncofertility Counseling of Young Breast Cancer Patients 161
Safety and feasibility of fasting‐mimicking diet and effects on nutritional status and circulating metabolic and inflammatory factors in cancer patients undergoing active treatment 160
Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis 159
Exploring the safety of chemotherapy for treating breast cancer during pregnancy 157
Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer 156
Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival A Randomized Clinical Trial 156
Gonadotropin Releasing Hormone Agonists Have an Anti-apoptotic Effect on Cumulus Cells 156
Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients 155
Anthracycline and taxane-based chemotherapy versus docetaxel and cyclophosphamide in the adjuvant treatment of HER2-negative breast cancer patients: a systematic review and meta-analysis of randomized controlled trials 155
Activity and safety of first-line treatments for advanced melanoma: A network meta-analysis 154
Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review 154
Is it safe to perform a controlled ovarian stimulation for assisted reproduction in young breast cancer survivors? 153
Letrozole withdrawal response in locally advanced breast cancer 153
Trastuzumab emtansine (T-DM1) as adjuvant treatment of HER2-positive early breast cancer: safety and efficacy 153
Improving Adjuvant Endocrine Treatment Tailoring in Premenopausal Women With Hormone Receptor-Positive Breast Cancer 152
The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients 151
Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting 151
Front-line liquid biopsy for early molecular assessment and treatment of hospitalized lung cancer patients 150
Ovarian suppression using luteinizing hormonereleasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: A meta-analysis of randomized studies 149
Fertility, sexuality and cancer in young adult women 149
Prognostic value of HER2-low status in breast cancer: a systematic review and meta-analysis 148
Effect of dose-dense adjuvant chemotherapy in hormone receptor positive/HER2-negative early breast cancer patients according to immunohistochemically defined luminal subtype: an exploratory analysis of the GIM2 trial 147
Treatment-induced early menopause and the protective role of gonadotropin-releasing hormone agonists during chemotherapy 146
Another step towards improving oncofertility counselling of young women with Hodgkin's lymphoma 145
Fertility and pregnancy issues in BRCA-mutated breast cancer patients 144
Role of fulvestrant in the treatment of postmenopausal metastatic breast cancer patients 144
Follow-up strategies for women treated for early breast cancer 144
Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: exploratory analysis of the GIM2 trial 144
Current State of the Art in the Adjuvant Systemic Treatment of Premenopausal Patients With Early Breast Cancer 142
Association between pertuzumab-associated diarrhoea and rash and survival outcomes in patients with HER2-positive metastatic breast cancer: Exploratory analysis from the CLEOPATRA trial 142
Reply to the letter to the editor 'Can ovarian suppression with gonadotropin releasing hormone analogs (GnRHa) preserve fertility in cancer patients?' by Rodriguez-Wallberg et al. 141
Knowledge, attitudes and practice of physicians towards fertility and pregnancy-related issues in young BRCA-mutated breast cancer patients 141
Post-neoadjuvant treatment and the management of residual disease in breast cancer: state of the art and perspectives 140
Impact of Taxanes, Endocrine Therapy, and Deleterious Germline BRCA Mutations on Anti-müllerian Hormone Levels in Early Breast Cancer Patients Treated With Anthracycline- and Cyclophosphamide-Based Chemotherapy 140
Combination therapies for the treatment of HER2-positive breast cancer: current and future prospects 140
Risk of adverse events with the addition of targeted agents to endocrine therapy in patients with hormone receptor-positive metastatic breast cancer: A systematic review and meta-analysis 139
Targeted agents for cancer treatment during pregnancy 139
A pooled analysis of the cardiac events in the trastuzumab adjuvant trials 138
Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literature 137
Temporary ovarian suppression during chemotherapy to preserve ovarian function and fertility in breast cancer patients: A GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology 137
Breast cancer diagnosed during pregnancy is associated with enrichment of non-silent mutations, mismatch repair deficiency signature and mucin mutations 136
Reply to the letter "Safety of fertility preservation in women with breast cancer" 136
Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trial 135
Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial 135
Tumor-to-nipple Distance Should Not Preclude Nipple-sparing Mastectomy in Breast Cancer Patients. Personal Experience and Literature Review 135
Implementing the hub and spoke model for the oncofertility units 134
Breast Cancer Surgery in the COVID-19 Pandemic: Validation of a Preventive Program for Patients and Health Care Workers 134
Adding a platinum agent to neoadjuvant chemotherapy for triple-negative breast cancer: the end of the debate 134
What medical oncologist residents think about the Italian speciality schools: A survey of the Italian Association of Medical Oncology (AIOM) on educational, clinical and research activities 133
Comparing the gonadotoxicity of multiple breast cancer regimens: Important understanding for managing breast cancer in pre-menopausal women 133
A retrospective study evaluating the impact of scattering radiation from imaging procedures on oocyte quality during ovarian stimulation for fertility preservation in young breast cancer patients 133
Pegfilgrastim for the prevention of chemotherapy-induced febrile neutropenia in patients with solid tumors 132
Prognostic implications of risk definitions from the monarchE and NATALEE trials 131
Controversies in Oncology: Surgery of the primary tumour in patients presenting with de novo metastatic breast cancer: to do or not to do? 131
Trastuzumab emtansine (T-DM1)-associated cardiotoxicity: Pooled analysis in advanced HER2-positive breast cancer 131
Approaches to Fertility Preservation for Young Women With Breast Cancer 130
Long-term safety of pregnancy following breast cancer according to estrogen receptor status 130
Triple-negative breast cancer: Current perspective on the evolving therapeutic landscape 130
Assessing the Impact of the COVID-19 Outbreak on the Attitudes and Practice of Italian Oncologists Toward Breast Cancer Care and Related Research Activities 130
Current practices in oncofertility counseling: updated evidence on fertility preservation and post-treatment pregnancies in young women affected by early breast cancer 128
The PREgnancy and FERtility (PREFER) Study Investigating the Need for Ovarian Function and/or Fertility Preservation Strategies in Premenopausal Women With Early Breast Cancer 128
Totale 15.908
Salva come PNG Salva come JPEG
Categoria #
all - tutte 124.965
article - articoli 124.463
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 502
Totale 249.930
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.205 0 0 108 237 58 230 82 523 278 259 98 332
2022/20232.027 265 194 38 162 269 260 53 186 376 16 186 22
2023/20241.623 53 153 38 198 111 143 93 112 87 113 135 387
2024/20254.968 141 376 97 278 671 541 525 768 242 250 490 589
2025/202611.950 1.011 471 1.365 962 1.217 922 1.668 569 840 1.176 750 999
2026/20271.940 1.007 515 418 0 0 0 0 0 0 0 0 0
Totale 32.631